Oncology and Cancer Screening (JOCS) is a peer-reviewed, Open Access journal which publishes original research articles, review articles, communication articles as well as editorials and clinical studies on current topics of oncology and cancer screening technology. The journal is maintained under Aditum Publications.
The journal endow with a multidisciplinary medium for clinical along with translational oncology research in the region of molecular pathology, genomics, diagnosis and therapy with a specific focus on molecular targeted agents, immune therapies and multidisciplinary approaches to cancer screening and prevention.
JOCS look for manuscripts with the aim comprise noteworthy advances in cancer research and that offer a translational association from the laboratory to the treatment center to unchain new prospects for understanding, prevention, identification and treatment of cancer.
Specific areas of interest include, but are not limited to: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Skin Cancer, Head and Neck Cancer, Paediatric Oncology, Neuro-oncology, Genitourinary Cancer, Soft Tissue and Bone Sarcomas, Palliative and Supportive Care tumor therapy; and epidemiology, mechanisms of development of the malignant phenotype and metastatic disease; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative research with probable applicability to clinical research.
JOCS consent to the rapid publication of accepted articles and the staging of outsized amount of data and additional information to make sure that research is distributed as resourcefully and promptly as potential to the scientific society.
This journal is a member of and promises to the principles of the Committee on Publication Ethics (COPE).
Open Access Publication and Creative Commons Licensing:
This is an online open access bimonthly journal, and all articles published under this are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share A like 4.0 License, which allows others to remix, share, tweak, and build upon the work non-commercially, as long as proper credit is given and the new conception are licensed under the identical terms.
Ahead of Print policy:
Articles published online under the Ahead of Print models are regarded as published and can be cited and quoted using the DOI as the reference source or with citation provided for every article. Aditum has a policy that corrections will not be made after publication of an article online without following accepted measures for making necessary corrections to the scientific record.
You can use this list to carry out a final check of your submission before you send it to the journal for review else you can coordinate with editorial coordinator for any queries.
Acute granulocytic leukemia
Advanced metastatic breast cancer
Anti-Cancer Drug Discovery
Autologous stem cell transplant
Cancer Prevention methods
Cellular Signal Pathways
DNA Repair and Apoptosis
Early Detection and Diagnosis
Hairy cell leukemia symptoms
Head and Neck Cancer
Hereditary prostate cancer genes
In situ non-invasive cancer
Intestinal cancer symptoms
Invasive lobular carcinoma
Metastatic ovarian cancer
Oat cell cancer symptoms
Oncology diagnostic tools
Pituitary gland cancer
Radiotherapy and biotherapy
Squamous cell carcinoma
Stem Cell Biology
Therapeutics of the drugs
Tumor and stem cell biology
Tumor immunology and virology